期刊论文详细信息
| The Journal of Clinical and Aesthetic Dermatology | |
| Dasatinib-induced Seborrheic Dermatitis-like Eruption | |
| Ryan R. Riahi1  | |
| 关键词: Antineoplastic; BRAF; chemotherapy; cutaneous; c-kit; dasatinib; melanoma; mucocutaneous; mucosal; seborrheic dermatitis; side effect; tyrosine kinase inhibitors; | |
| DOI : | |
| 学科分类:医学(综合) | |
| 来源: Matrix Medical Communications, LLC | |
PDF
|
|
【 摘 要 】
Dasatinib is an oral tyrosine kinase inhibitor approved for imatinib-resistant chronic myelogenous leukemia. It has been investigated in treating other neoplasms, including non-small-cell lung cancer and a subset of melanomas. Seborrheic dermatitis is ...
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201901225152527ZK.pdf | 185KB |
PDF